Refine by
Wound Healing Technology Articles & Analysis
14 news found
The acquisition enables Healiva® to establish one of the world’s broadest portfolios of affordable, personalized, end-to-end wound care consisting of enzyme technology, autologous & allogenic cell therapies, and medical devices. ...
Microbion Corporation of Bozeman, MT, today announced that it has received non-dilutive funding through its strategic partnership with CUBRC, Inc., a Buffalo-based, independent not-for-profit research company, of up to $2.1 million from the US Navy through the Medical Technology Enterprise Consortium (MTEC) partnership. The funding project is titled “Pravibismane Suspension ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
Through the acquisition of the UltraMIST® assets in 2020, SANUWAVE has added the patents and patent applications related to the non-contact and low-frequency ultrasound technology incorporated into the UltraMIST System. The patent portfolio covers specific constructions for ultrasound systems, combination systems, drug delivery, and methods to apply such ultrasound ...
Cuts and lacerations are among the most common complaints that bring patients to urgent care clinics. Whether a wound originates from an accident with a sharp object, such as a kitchen knife or yard tool, or from a blunt force such as a fall, there may be a risk of infection. Urgent care providers are responsible for providing treatment that promotes healing and helps prevent wound infection. ...
There are a number of factors that can impact patient satisfaction, including the courtesy and respect patients feel while in the care facility, the clarity of the information provided, and urgent care wait times. The Link Between Wait Time and Patient Satisfaction Research shows that every aspect of the patient experience can be negatively impacted by long wait times, including how patients ...
Dermatologists may perform a number of in-office procedures that result in wounds, including biopsies and mole excisions. Traditional options for repairing these wounds include sutures, staples, adhesive strips, and other suture types. However, traditional wound care methods have several drawbacks, including cost, time, and patient limitations. New wound closure options, such as the microMend ...
Improving dermatology patients’ experience during dermatology procedures means more than simply providing top-notch aesthetic treatment. It requires thoughtful interactions that address every aspect of the patient's visit including their physical comfort, emotional state, and socioeconomic status. Patients increasingly choose healthcare providers who can respond to their specific needs. ...
The medical field uses advanced technology in all facets of daily operations. Patient intake forms, record keeping, communication portals, invoicing, and of course, procedures are enhanced by technological advances. Those advances are now shaping dermatology wound care too. Besides improved patient experience and clinical outcomes, technological advances can also positively affect a ...
The results of this case study are another indication that treatment of Diabetic Foot Ulcers with the dermaPACE System prepares the wound bed via oxygenation and neo-vascularization, facilitating accelerated wound resolution via the body's natural healing process or preparing the wound to more readily respond to other advanced ...
The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound care pathway through its portfolio of noninvasive and biological response therapeutics that help expedite the wound healing process at the cellular level, resulting in less time and resources spent on more costly treatments. ...
August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. The vascular closure device consists of an insertion sheath, dilator and an implant contained in a delivery system. It uses a patch placed against the artery wall ...
Clyra Medical Technologies holds the exclusive license to commercialize BioLargo's technology in the Advanced Wound Care industry. ...
BioLargo, Inc. (OTCBB: BLGO) announced today that former Smith & Nephew Vice President of Innovation (and Vice President at Smith & Nephew Wound Management) Tanya Rhodes has joined the BioLargo management team as a senior strategy advisor. Rhodes will work closely with BioLargo and its recently formed medical subsidiary to commercialize its technology in the wound management and medical ...